Clinical trial
Minimally Invasive Interval Debulking Surgery in Ovarian Cancer
NCT03378128 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Minimally Invasive Interval Debulking Surgery in Ovarian Cancer
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 12, 2018
- Completion date
- April 30, 2020
- Enrollment
- 50 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
malignant neoplasm of fallopian tube, malignant neoplasm of ovary, malignant neoplasm of peritoneum